Related Experiment Video
Updated: Dec 23, 2025

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Fucoidan Induces Apoptosis of HT-29 Cells via the Activation of DR4 and Mitochondrial Pathway
Abstract:
Fucoidan has a variety of pharmacological activities, but the understanding of the mechanism of fucoidan-induced apoptosis of colorectal cancer cells remains limited. The results of the present study demonstrated that the JNK signaling pathway is involved in the activation of apoptosis in colorectal cancer-derived HT-29 cells, and fucoidan induces apoptosis by activation of the DR4 at the transcriptional and protein levels. The survival rate of HT-29 cells was approximately 40% in the presence of 800 μg/mL of fucoidan, but was increased to 70% after DR4 was silenced by siRNA. Additionally, fucoidan has been shown to reduce the mitochondrial membrane potential and destroy the integrity of mitochondrial membrane. In the presence of an inhibitor of cytochrome C inhibitor and DR4 siRNA or the presence of cytochrome C inhibitor only, the cell survival rate was significantly higher than when cells were treated with DR4 siRNA only. These data indicate that both the DR4 and the mitochondrial pathways contribute to fucoidan-induced apoptosis of HT-29 cells, and the extrinsic pathway is upstream of the intrinsic pathway. In conclusion, the current work identified the mechanism of fucoidan-induced apoptosis and provided a novel theoretical basis for the future development of clinical applications of fucoidan as a drug.
Insights
Fucoidan triggers colorectal cancer cell death by activating the DR4 receptor and mitochondrial pathways. This study elucidates fucoidan
Area of Science:
- Marine biotechnology
- Cancer research
- Molecular biology
Background:
- Fucoidan exhibits diverse pharmacological effects.
- The precise mechanism of fucoidan-induced apoptosis in colorectal cancer (CRC) cells requires further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms underlying fucoidan-induced apoptosis in HT-29 CRC cells.
- To identify the specific signaling pathways and molecular targets involved in fucoidan's anti-cancer effects.
Main Methods:
- Utilized HT-29 colorectal cancer cells.
- Employed siRNA to silence DR4 expression.
- Assessed cell viability, mitochondrial membrane potential, and cytochrome C release.
- Investigated DR4 activation at transcriptional and protein levels.
Main Results:
- Fucoidan induced apoptosis in HT-29 cells via JNK signaling pathway activation.
- Fucoidan upregulated DR4 expression, contributing to apoptosis.
- Silencing DR4 significantly increased cell survival.
- Fucoidan disrupted mitochondrial membrane potential and integrity.
- Both DR4 (extrinsic) and mitochondrial (intrinsic) pathways are involved, with the extrinsic pathway acting upstream.
Conclusions:
- Fucoidan induces colorectal cancer cell apoptosis through a mechanism involving DR4 activation and mitochondrial dysfunction.
- The extrinsic pathway initiated by DR4 activation precedes the intrinsic mitochondrial pathway.
- This study provides a mechanistic basis for fucoidan's potential as a CRC therapeutic agent.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
04:20Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis